Focus on patient outcomes
Using information technology to improve health
Information technology is already having a significant impact on healthcare innovation and presents vast untapped potential.
Recent research shows that patients now better understand the benefits of technology and are embracing it to improve their health. In recent market research carried out for Novartis, 92 percent of patients and 84 percent of seniors said that they were comfortable using technology. Almost two-thirds of patients also think that technology is helping them to better manage their health.
Novartis defines e-health and m-health as the healthcare system's adoption of the channels and tools of the digital and mobile world: the digitization of healthcare.
E-Health is reshaping the entire healthcare system which exists to deliver interventions such as diagnosis, medicines, care and advice, and technology is impacting every aspect.
Novartis is committed to investing in valuable, innovative technologies and has initiated a number of pilot programs using remote monitoring devices. These devices may someday provide physicians with a wealth of information to proactively manage the health of patients by monitoring adherence to treatment.
In addition, Novartis has developed a number of online communities and mobile apps that help patients better manage their own health.
Novartis expects these new technologies to help it remain successful despite a tougher economic environment, but their development also puts a premium on new capabilities.
To help improve the selectivity and reliability of medical care, Novartis launched its Molecular Diagnostics unit in 2008 to develop diagnostic tests that identify patient subgroups that may have a positive response to treatment as well as to monitor subsequent disease progression and response. Within a few years, it is expected that the use of companion diagnostics with drugs will become increasingly common to demonstrate to payors and regulators predictable outcomes for patient success. Novartis goal is to be at the forefront of this innovative change that is central to our strategy to deliver the right dose of the right drug to the right patient at the right time.
